{"id":"W3097644161","doi":"10.1182/blood-2020-137183","title":"Selinexor in Combination with Carfilzomib and Dexamethasone, All Once Weekly (SKd), for Patients with Relapsed/Refractory Multiple Myeloma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital; Princess Margaret Cancer Centre; Dalhousie University; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Dexamethasone; Internal medicine; Multiple myeloma; Adverse effect; Refractory (planetary science); Neutropenia; Oncology; Lenalidomide; Proteasome inhibitor; Pharmacology; Cancer research; Gastroenterology; Toxicity; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002579469,0.0003717616,0.0008098396,0.0003110998,0.0002083888,0.0003320492,0.0003146593,0.0003345053,0.001728823],"category_scores_gemma":[0.0002741722,0.0001283949,0.0005183448,0.0002914384,0.0001840694,0.0002972661,0.0001757561,0.0008026207,0.0004333255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000477577,"about_ca_system_score_gemma":0.0003812263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006457435,"about_ca_topic_score_gemma":0.003456965,"domain_scores_codex":[0.9998971,0.00002593217,0.00001155682,0.00001964056,0.00002091944,0.00002480954],"domain_scores_gemma":[0.9998856,0.00001784433,0.00003384916,0.000006297372,0.000007771998,0.00004867608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.08930025,0.005272515,0.04564187,0.001869974,0.001460139,0.002798241,0.0003964655,0.00247219,0.07518919,0.0004856795,0.01022286,0.7648906],"study_design_scores_gemma":[0.1135264,0.2686368,0.4284357,0.000678215,0.003422102,0.01704359,0.0005349136,0.01033453,0.04711895,0.00138291,0.108736,0.0001498062],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9721254,0.02006133,0.0006472821,0.001807229,0.0001598691,0.0003879778,0.0004191193,0.0001797941,0.004212045],"genre_scores_gemma":[0.9939457,0.003157698,0.0006114431,0.0004726922,0.00008949396,0.00008873834,0.0003312409,0.000008073266,0.001295058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001728823,"threshold_uncertainty_score":0.005783498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02280759740823557,"score_gpt":0.2645409406002516,"score_spread":0.241733343192016,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}